Accendra Health (ACH) EV to EBITDA (2009 - 2026)

Accendra Health (ACH) has reported EV to EBITDA for 18 consecutive years, with 7.26 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA rose 56.57% year-over-year to 7.26 in Q2 2026; TTM through Jun 2026 was 8.7, a 442.54% increase from a year earlier, with the FY2025 full-year figure at 2.48, up 44.98% from the prior year.
• EV to EBITDA was 7.26 for Q2 2026 at Accendra Health, up from 9.48 in the prior quarter.
• Over five years, EV to EBITDA peaked at 193.23 in Q1 2024 and troughed at 26.56 in Q4 2022.
• A 5-year average of 35.47 and a median of 30.18 in 2022 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA slumped 151.06% in 2022 and jumped 246.22% in 2023, its largest moves.
• Over 5 years, EV to EBITDA stood at 26.56 in 2022, then surged by 152.27% to 13.88 in 2023, then tumbled by 125.92% to 3.6 in 2024, then advanced by 9.5% to 3.26 in 2025, then tumbled by 123.05% to 7.26 in 2026.
• The last three EV to EBITDA figures came in at 7.26 (Q2 2026), 9.48 (Q1 2026), and 3.26 (Q4 2025), per Business Quant data.